TET enzymes as guardians of genome stability

TET 酶作为基因组稳定性的守护者

基本信息

  • 批准号:
    10477020
  • 负责人:
  • 金额:
    $ 105.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Project summary/ abstract In 2009, my laboratory discovered the enzymatic activities of the three mammalian TET (Ten-Eleven-Translo- cation) proteins, TET1, TET2 and TET3. Since then, work from our own and other groups has implicated TET proteins in regulating gene expression, cell lineage specification, embryonic development, neuronal function and cancer. TET proteins are dioxygenases that oxidize 5-methylcytosine (5mc) to 5-hydroxymethylcytosine (5hmC) and further oxidized methylcytosines (oxi-mC). They have two biochemical functions: to generate oxi- mC and to facilitate DNA demethylation. However, the mechanisms by which TET proteins exert their diverse biological effects are much less understood. TET2 mutations are frequently observed in myeloid malignancies, but many other cancers are documented to have low 5hmC levels, implying profound loss of TET function even in the absence of TET coding region muta- tions. Because TET loss-of-function is associated with increased DNA methylation, the tumor suppressive role of TET proteins has been assumed to involve their ability to maintain DNA in a demethylated state. However, in powerful, inducible mouse models developed in our laboratory, we have shown that acute deletion of both Tet2 and Tet3 rapidly induces an aggressive, transmissible myeloid leukemia within 4 weeks and with 100% penetrance. Using this system, we have found that while the average level of DNA methylation increases across expressed genes in early hematopoietic stem/precursor cells as expected, there is little or no correla- tion of increased or decreased DNA methylation with up- or down-regulation of gene expression or with onco- genesis. Instead, we observe a strong correlation of oncogenic transformation with increased phospho-H2AX and impaired DNA damage repair. Here we propose to extend these studies to address the mechanisms involved. In this project we will use mouse models as well as in vitro systems to analyze the mechanisms of oncogenesis induced by TET loss-of-function. We will examine the role of TET catalytic activity, and compare the conse- quences of loss-of-function of TET proteins versus DNA methyltransferases (DNMTs). We will examine the kinetic relation between loss of oxi-mC in expanding cells and the development of replication stress, genome instability and chromosomal aberrations. As feasible, we will perform RNAi/CRISPR screens to identify important players that regulate cell expansion induced by TET loss-of-function. We will extend our findings to human cancers with high and low 5hmC. Our studies have the potential to change current paradigms and suggest new therapeutic approaches, by defining the mechanisms by which TET function is linked to genome stability.
项目概要/摘要 2009年,我的实验室发现了三种哺乳动物TET(Ten-Eleven-Translo- 阳离子)蛋白质、TET1、TET2 和 TET3。从那时起,我们自己和其他小组的工作就涉及到 TET 调节基因表达、细胞谱系规范、胚胎发育、神经元功能的蛋白质 和癌症。 TET 蛋白是将 5-甲基胞嘧啶 (5mc) 氧化为 5-羟甲基胞嘧啶的双加氧酶 (5hmC) 和进一步氧化的甲基胞嘧啶 (oxi-mC)。它们有两个生化功能:产生氧化 mC 并促进 DNA 去甲基化。然而,TET 蛋白发挥其多样性的机制 生物效应的了解要少得多。 TET2 突变常见于骨髓恶性肿瘤,但许多其他癌症也有记录 5hmC 水平较低,这意味着即使没有 TET 编码区突变,TET 功能也会严重丧失 系统蒸发散。由于 TET 功能丧失与 DNA 甲基化增加有关,因此肿瘤抑制作用 TET 蛋白的功能被认为涉及其维持 DNA 去甲基化状态的能力。然而, 在我们实验室开发的强大的诱导型小鼠模型中,我们已经证明,两种基因的急性缺失 Tet2 和 Tet3 在 4 周内迅速诱发侵袭性、传染性骨髓性白血病,且 100% 外显率。使用这个系统,我们发现虽然 DNA 甲基化的平均水平增加 正如预期的那样,在早期造血干/前体细胞中表达的基因中,几乎没有或没有相关性 DNA 甲基化的增加或减少与基因表达的上调或下调或肿瘤相关 起源。相反,我们观察到致癌转化与磷酸化 H2AX 增加有很强的相关性 以及 DNA 损伤修复受损。在这里,我们建议扩展这些研究以解决机制 涉及。 在这个项目中,我们将使用小鼠模型和体外系统来分析肿瘤发生的机制 由 TET 功能丧失引起。我们将研究 TET 催化活性的作用,并比较结果 TET 蛋白与 DNA 甲基转移酶 (DNMT) 功能丧失的序列。我们将检查 扩增细胞中 oxi-mC 丢失与复制应激、基因组发展之间的动力学关系 不稳定和染色体畸变。如果可行,我们将进行 RNAi/CRISPR 筛选来识别 调节 TET 功能丧失引起的细胞扩张的重要参与者。我们将把我们的发现扩展到 具有高和低 5hmC 的人类癌症。我们的研究有可能改变当前的范式 通过定义 TET 功能与基因组关联的机制,提出新的治疗方法 稳定。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of single nanoparticle-nanopore interaction strength on ionic current modulation.
  • DOI:
    10.1016/j.snb.2020.128785
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sohini Pal;Ramkumar B.;S. Jugade;A. Rao;A. Naik;B. Chakraborty;M. Varma
  • 通讯作者:
    Sohini Pal;Ramkumar B.;S. Jugade;A. Rao;A. Naik;B. Chakraborty;M. Varma
Active DNA demethylation damages DNA.
  • DOI:
    10.1126/science.adf3171
  • 发表时间:
    2022-12-02
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.
  • DOI:
    10.7554/elife.66973
  • 发表时间:
    2021-12-17
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Stoyanova E;Riad M;Rao A;Heintz N
  • 通讯作者:
    Heintz N
Lineage-specific functions of TET1 in the postimplantation mouse embryo.
  • DOI:
    10.1038/ng.3868
  • 发表时间:
    2017-07
  • 期刊:
  • 影响因子:
    30.8
  • 作者:
    Khoueiry R;Sohni A;Thienpont B;Luo X;Velde JV;Bartoccetti M;Boeckx B;Zwijsen A;Rao A;Lambrechts D;Koh KP
  • 通讯作者:
    Koh KP
Unusual Activity of a Chlamydomonas TET/JBP Family Enzyme.
  • DOI:
    10.1021/acs.biochem.9b00609
  • 发表时间:
    2019-08
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    L. Aravind;S. Balasubramanian;A. Rao
  • 通讯作者:
    L. Aravind;S. Balasubramanian;A. Rao
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anjana Rao其他文献

Anjana Rao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anjana Rao', 18)}}的其他基金

Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10441261
  • 财政年份:
    2020
  • 资助金额:
    $ 105.84万
  • 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10819075
  • 财政年份:
    2020
  • 资助金额:
    $ 105.84万
  • 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10202515
  • 财政年份:
    2020
  • 资助金额:
    $ 105.84万
  • 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10665608
  • 财政年份:
    2020
  • 资助金额:
    $ 105.84万
  • 项目类别:
Epigenetic control of Foxp3 expression in induced T regulatory cells
诱导 T 调节细胞中 Foxp3 表达的表观遗传控制
  • 批准号:
    10166759
  • 财政年份:
    2017
  • 资助金额:
    $ 105.84万
  • 项目类别:
Investigating the role of TET deficiency in promoting T cell expansion and inflammation
研究 TET 缺陷在促进 T 细胞扩增和炎症中的作用
  • 批准号:
    10522926
  • 财政年份:
    2017
  • 资助金额:
    $ 105.84万
  • 项目类别:
Investigating the role of TET deficiency in promoting T cell expansion and inflammation
研究 TET 缺陷在促进 T 细胞扩增和炎症中的作用
  • 批准号:
    10640187
  • 财政年份:
    2017
  • 资助金额:
    $ 105.84万
  • 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
  • 批准号:
    9978730
  • 财政年份:
    2016
  • 资助金额:
    $ 105.84万
  • 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
  • 批准号:
    9342700
  • 财政年份:
    2016
  • 资助金额:
    $ 105.84万
  • 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
  • 批准号:
    10246473
  • 财政年份:
    2016
  • 资助金额:
    $ 105.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 105.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了